Strategic Partnerships Smartpatient is actively expanding its DTP and patient support ecosystem through collaborations with major pharma players such as Novo Nordisk and UCB, indicating ongoing opportunity to cross-sell expanded digital health programs and disease-specific modules to sponsor brands.

Diabetes Program Growth Recent launches of digital support programs for Type 2 diabetes in Germany with Novo Nordisk suggest a ready-to-pitch vertical expansion area for additional diabetes treatments and country expansions leveraging the MyTherapy platform.

Scaleable Patient Engagement With the MyTherapy app reaching millions of active patients, there is a proven, scalable channel for pharma partners to deploy digital activation, adherence programs, and real-world insights across diverse therapeutic areas.

Global Market Readiness The company operates in Europe and partners with global pharma (e.g., Novo Nordisk, UCB), signaling receptivity to multinational deployments and the need for solutions that support regulatory compliance, localization, and large-scale implementation.

Analytics and Tech Advantage An integrated tech stack including Databricks, Google BigQuery, Azure and analytics-driven workflows positions smartpatient to offer data-driven patient insights, outcome measurement, and tailored digital health coaching to sponsors seeking measurable ROI.